Nailesh Bhatt - Net Worth and Insider Trading
Nailesh Bhatt Net Worth
The estimated net worth of Nailesh Bhatt is at least $50,709 dollars as of 2024-05-26. Nailesh Bhatt is the Director of Sonnet BioTherapeutics Holdings Inc and owns about 30,733 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $50,709. Details can be seen in Nailesh Bhatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nailesh Bhatt has not made any transactions after 2023-05-17 and currently still holds the listed stock(s).
Transaction Summary of Nailesh Bhatt
Nailesh Bhatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nailesh Bhatt owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of Nailesh Bhatt’s form 4 insider trades.
Insider Ownership Summary of Nailesh Bhatt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-17 | director |
Nailesh Bhatt Latest Holdings Summary
Nailesh Bhatt currently owns a total of 1 stock. Nailesh Bhatt owns 30,733 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of May 17, 2023, with a value of $50,709.
Latest Holdings of Nailesh Bhatt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-05-17 | 30,733 | 1.65 | 50,709 |
Holding Weightings of Nailesh Bhatt
Nailesh Bhatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Nailesh Bhatt has made a total of 1 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 25,000 shares on May 17, 2023, which cost Nailesh Bhatt around $5,750.
Insider Trading History of Nailesh Bhatt
- 1
Nailesh Bhatt Trading Performance
GuruFocus tracks the stock performance after each of Nailesh Bhatt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nailesh Bhatt is 49.98%. GuruFocus also compares Nailesh Bhatt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nailesh Bhatt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nailesh Bhatt's insider trading performs compared to the benchmark.
Performance of Nailesh Bhatt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 262.21 | | | | | |
| Relative Return to S&P 500(%) | 256.18 | | | | | |
Nailesh Bhatt Ownership Network
Nailesh Bhatt Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Nailesh Bhatt is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Nailesh Bhatt made 1 insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN) with a net purchase of 25,000. Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 431,600 shares made by Pankaj Mohan , a net purchase of 23,255 shares made by Albert D. Dyrness , and a net purchase of 10,000 shares made by Susan Dexter .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 489,855 shares were bought by its insiders, resulting in a net purchase of 489,855 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Nailesh Bhatt Mailing Address
Above is the net worth, insider trading, and ownership report for Nailesh Bhatt. You might contact Nailesh Bhatt via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
